INTRODUCTION
The epithelial mucins are a family of secreted and cell-surface glycoproteins expressed by ductal and glandular epithelial tissues. Members of this family are characterized by a tandem repeat structure which comprises most of the protein backbone and is the scaffold for a large number of complex O-linked carbohydrate side chains. Twelve human epithelial mucin genes have been identified to date, and it is now clear that there are two structurally and functionally distinct classes of mucins: secreted gel-forming mucins and transmembrane mucins.
Gel-forming mucins are secreted by goblet cells and are the major constituent of mucus which protects and lubricates epithelial surfaces, particularly those of the gastrointestinal, respiratory and reproductive tracts. These mucins undergo homo-oligomerization and are clearly the critical contributors to the biophysical properties of mucus (1) . The gel-forming mucins are encoded by a cluster of four mucin genes (MUC2, MUC5AC, MUC5B, MUC6) on chromosome band 11p15.5 (2) . The MUC7 gene encodes a relatively small secreted salivary mucin (3) and MUC9 is a relatively small secreted mucin expressed only in the Fallopian tube (4) . The MUC8 cDNA, expressed in respiratory tissue, has not been well characterized (5) .
It has recently emerged that there is a large family of epithelial transmembrane mucins, many members of which are highly expressed in the gastrointestinal tract, particularly in the large intestine. The MUC1 gene encodes a transmembrane mucin expressed by almost all human glandular epithelial tissues and throughout all regions of the gastrointestinal tract (6) . The MUC3 and MUC4 genes were initially thought to encode secreted mucins, however, it has recently been shown that these genes encode transmembrane mucins as their dominant isoforms (7, 8) . There is by guest on http://www.jbc.org/ Downloaded from 4 a newly identified cluster of transmembrane mucin genes located on chromosome band 7q22 (9) .
Members of this cluster include the closely related MUC3 and MUC12 genes (10, 9) . MUC3 is most highly expressed in the small intestine, whilst MUC12 is most highly expressed in the colon (9) . Further genes may also lie in this cluster and the genomic organization of these genes should be clarified shortly by the human genome project. The MUC4 gene located on chromosome band 3q29 appears to be related to genes in the 7q22 cluster as the mucin it encodes contains a similar domain structure, and although most highly expressed in the tracheobronchus, is also present in the intestine (8, 11) .
Common structural features shared by all the identified transmembrane mucins include C-terminal cytoplasmic domains with motifs suggestive of a role in signal transduction, a SEA module in the extracellular domain (12) and a large mucin domain at the N-terminus of the extracellular sub-unit. The two mucins studied biochemically to date, human MUC1 and rat Muc4, undergo cleavage and non-covalent reassociation during biosynthesis, with disruption of this association allowing shedding of the mucin domain from the cell surface (13, 14) . Thus, the ability to shed a large mucin protein from the cell-surface and the ability to transmit signals have both been heavily conserved. In addition, MUC3, MUC4 and MUC12 all contain two cysteinerich EGF-like domains, one either side of the SEA module. The function of EGF-like motifs in these mucins is unclear although there is evidence implicating these domains in epithelial growth modulation (15) .
In the present investigation we have used database mining to identify a novel human transmembrane mucin gene that has been designated MUC13 by the HUGO Gene Nomenclature Committee. The rodent orthologues of MUC13 have been previously identified and were thought to be restricted to expression in hemopoietic precursor cells in bone marrow (16) . We describe the cDNA sequence of human MUC13 and show that the putative protein has the same domain organization as MUC3, MUC4 and MUC12, and similarities to MUC1. We also demonstrate that both the human and mouse genes are expressed predominantly in epithelial tissues, particularly those of the gastrointestinal tract, and demonstrate the human protein on the epithelial apical membrane and within goblet cell thecae of gastrointestinal epithelia. Initial biochemical characterization indicates that MUC13 is cleaved into two subunits and that the subunit containing the cytoplasmic tail undergoes homo-dimerization. A human RNA Multiple Tissue Expression Array (Clontech, Palo Alto, CA, catalogue number 7775-1) was used to examine MUC13 expression in normal human tissues (RNA from 71 adult tissues, seven fetal tissues and eight cancer cell lines). The MUC13 cDNA probe (as above) was hybridized as per the manufacturer's instructions. Levels of expression were quantitated using a scanning densitometer and Molecular Analyst software (Biorad Laboratories, Regents Park, NSW). Signal intensity was expressed relative to the sample with highest levels of expression since loading of RNA samples on the array had previously been normalized using eight housekeeping genes by the manufacturer.
EXPERIMENTAL PROCEDURES

Identification and Cloning of the Human
Mouse intestinal cDNA was amplified by RT-PCR to yield a 768 bp PCR product (corresponding to nucleotides 182-950 in GenBank Accession No. J04634) that was cloned into pGEM-T and sequenced. Riboprobes were made by in vitro transcription of DNA with T7 and SP6 RNA polymerases and incorporation of digoxigenin-labeled uridine triphosphate (Roche, Castle Hill, NSW). Approval for collection of animal tissues was obtained from the University of Queensland Animal Experimentation Ethics Committee. Murine epithelial tissues and spleen were fixed for 4 h in fresh 4% paraformaldehyde in 10 mM phosphate buffered saline 7 pH 7.2 (PBS), embedded in paraffin and sectioned. Hybridization and washing conditions were modified from that previously described (18) . Anti-sense and sense probes at 1 ug/mL in ULTRAhyb (Ambion, Austin, Texas) were hybridized to sections overnight at 48 o C. The reaction was visualized with 4-bromo-5-chloro-3-indolylphosphate and nitroblue tetrazolium (BCIP/NBT) substrate (Roche) also overnight. Sections were counterstained with nuclear fast red, dehydrated, cleared and mounted in DePeX.
Chromosomal Localization of MUC13 by Fluorescence in situ Hybridization-The
MUC13 cDNA probe (as above) was nick translated with biotin-14-dATP and hybridized in situ at a final concentration of 10 ng/ul to metaphases from two normal males. The fluorescence in situ hybridization (FISH) method was modified from that previously described (19) , in that chromosomes were stained before analysis with both propidium iodide as counterstain and DAPI for chromosome identification. Images of metaphase preparations were captured by a cooled CCD camera using the CytoVision Ultra image collection and enhancement system (Applied Imaging Corporation, Sunderland, UK).
Production of MUC13-reactive polyclonal antibodies. Three synthetic peptides were synthesized (Auspep, Parkville, Australia) corresponding to three hydrophilic sequences of the putative MUC13 amino acid sequence, each with an terminal cysteine residue added: an extracellular domain epitope (peptide A, DPEEKHSMAYQDLHSEC, amino acids 229-244 in Figure 1 ) and two cytoplasmic tail epitopes (peptide B, CRSNNTKHIEEENLID amino acids 446-461 in Figure 1 and peptide C, CMQNPYSRHSSMPRPDY amino acids 497-512 in Figure   1 ). These peptides were conjugated to bovine serum albumin using glutaraldehyde (20) . Six Immunohistochemical detection of human MUC13 in epithelial tissues. Polyclonal MUC13 peptide-reactive mouse sera were used to detect MUC13 in paraffin sections of normal and diseased human gastrointestinal epithelial tissues. Immunohistochemistical techniques were as previously described (21) with peptide A and B reactive sera diluted 1/100 and tissue sections subject to antigen retrieval by boiling in 0.1 M citric acid pH 6, and peptide C reactive sera diluted 1/400 with antigen retrieval not used.
Biochemical Characterization of the MUC13 protein. Colorectal cancer cell lines
LIM2463 and LS513 were maintained in RPMI 1640 containing 10% foetal bovine serum, and routinely passaged by trypsin digestion. Monolayers of cells were washed with ice-cold PBS and lysed, with rocking for 30 min, using a variety of ice-cold lysis buffers including: RIPA (50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1 mM PMSF, pH 7.5), NP40 (50 mM Tris, 150 mM NaCl, 0.5% NP40, 1 mM PMSF, pH 7.5), BRIJ97 (50 mM Tris, 150 mM NaCl, 0.5% Brij97, 1 mM aprotinin, pH 7.6) and TX100 (50 mM Tris, 150 mM NaCl, 0.5% Triton X-100, 1 mM PMSF, pH 7.5). Cell surface proteins were biotinylated by incubating cell 9 monolayers with 0.5 mg/mL biotinamidocaproic acid 3-sulfo-N-hydroxy succinimide (Sigma, St Louis, MO) in PBS with 0.1 mM CaCl 2 and 1 mM MgCl 2 , followed by lysis as above. MUC13 was immunoprecipitated with polyclonal antisera against peptides A (1/100 dilution), B (1/100) or C (1/400) or with antisera raised against irrelevant conjugated peptides as a control, using previously described methods (22) immunoprecipitates were prepared in SDS-PAGE buffer containing 2% SDS, with and without 5% 2-mercaptoethanol, subjected to electrophoresis either in 4-20% gradient or 10% resolving gels with 3% stacking gels, and electrotransferred to PVDF or nitrocellulose membranes as described (22) . Benchmark TM prestained Mr markers were included on each gel (Life Technologies). Western blotting was performed as previously described (22) . Briefly, membranes were blocked with 10% skim milk powder and MUC13 was detected using polyclonal antisera against peptides A (1/400 dilution), B (1/400) or C (1/4000) followed by donkey anti-mouse HRP conjugate (Jackson Laboratories) and ECL detection (Amersham Pharmacia). Specific carbohydrates were detected using 2 µg/mL of Helix pomatia and Arachis hypogaea lectins (Sigma). Immunoprecipitated biotinylated proteins and biotinylated lectins were detected with streptavidin-HRP conjugate (Zymed Laboratories, San Francisco, CA) diluted 1/2000 followed by ECL detection. Da, and has an identical domain structure (exemplified in Figure 2 ) to the previously described murine protein (16) . At the N-terminus is a signal peptide for the secretory pathway with cleavage predicted between residues 19 and 20 (23) . The signal peptide is followed by a serine However, an EST (GenBank accession no. AI431674) appears to have been derived from alternative use of the non-consensus polyadenylation signal, suggesting that smaller human MUC13 transcripts do exist, but are probably rare.
RESULTS
Identification and Cloning of the
Fluorescence in situ Hybridization-Chromosomal localization studies using fluorescence in situ hybridization mapped the human gene to chromosome band 3q13.3 ( Figure 4A ).
Comparison of Human MUC13 with Rat and Mouse Orthologues-Amino acid alignment
of the carboxy terminus of the human MUC13 mucin with its rodent orthologues, revealed 52% identity to its mouse and rat counterparts (see Figure 5 ). The N-terminal mucin domain shows significant divergence from the rodent proteins which possess a near perfect repeat structure Expression of MUC13 mRNA in Human Tissues-Hybridization of MUC13 using a multiple tissue expression array demonstrated that MUC13 is expressed at highest levels in the large intestine and the trachea, and is also expressed at relatively high levels in the kidney, small intestine, appendix and stomach (see Figure 6 ). After long exposures, low levels of expression were also identified in pancreas, prostate, uterus, lung, liver, adrenal gland, spleen, peripheral blood leucocytes, lymph node, bone marrow, testis and ovary. Figure 4G ). In the body of the stomach, MUC13 was expressed on the apical membrane surface of cells of the surface epithelium, the gastric pits, and the more peripheral glands but only occasionally in the deep glands (see Figure 4H ). In addition, in the gastric glands occasional by guest on http://www.jbc.org/ Downloaded from mucus neck cells showed intense granular cytoplasmic staining (see Figure 4H ). Some mucus cells of the surface epithelium and gastric pits also showed moderate cytoplasmic reactivity, and in some cells supranuclear staining was also observed. In the pyloric and cardiac stomach some of the deep glands showed moderate to strong cytoplasmic expression of MUC13, whilst adjacent glands were often negative ( Figure 4I ). In the duodenum, MUC13 was detected in supranuclear vacuoles within all absorptive cells, consistent with detection in the Golgi region, however, apical membrane staining was not seen (see Figure 4J ). MUC13 was also expressed on the apical membrane of epithelial cells lining pancreatic ducts (not shown).
In the terminal ileum of the small intestine, MUC13 was detected as intense staining of the apical membrane of all cells deep in the crypts (see Figure 4K ) and less frequent apical membrane staining of cells of the surface epithelium (see Figure 4L ). Both goblet and columnar cells appeared to express cell surface MUC13, however, staining was more intense in columnar cells and at high power a microvillous-type pattern was observed. Secreted material in the crypt lumen also stained. In addition, moderate to weak staining in mesh network and punctate patterns was also seen within the thecae of goblet cells in the villi (see Figure 4L ) but only rarely deep in the crypts (see Figure 4K ). The staining of goblet cell thecae was more pronounced using peptide A-reactive antisera than C-reactive antisera (not shown). Appendix showed strong MUC13 immunoreactivity both in the cytoplasm and on the cell surface of both goblet and columnar cells, with very strong cytoplasmic reactivity in columnar cells (see Figure 4M ). In the colon, MUC13 was, similarly to the terminal ileum, highly expressed on the apical membrane surface of both columnar and goblet cells deep in the crypts (see Figure 4N ). In addition, supranuclear vacuolar staining, like that seen in the duodenum, also observed in these cells together with reactivity with secreted material. Occassional columnar cell apical membrane staining was observed on the colonic surface epithelium together with goblet cell thecal staining, although this was less intense than that seen in the terminal ileum.
In a small series of colorectal cancers examined, MUC13 was expressed in the cytoplasm and on the cell surface of cancer cells, however, expression of MUC13 was often low relative to normal tissue and was typically heterogeneous in nature (see Figure 4O ). Only very rarely nonepithelial cells in the stroma or lymphoid patches of intestinal tissues showed weak membrane staining for MUC13 (not shown). Because it was suspected that MUC13 may be cleaved into two subunits and because these subunits may disassociate from each other in harsh detergents as has been demonstrated for MUC1 (22), we also immunoprecipitated MUC13 in several lysis buffers utilizing milder detergents. Using the milder detergents under non-reducing conditions, in addition to the 47 and 93 kDa bands, a prominent high Mr band at approximately 520 kDa was observed (see Figure 9 ).
Biochemical Characterization of the human MUC13 protein-
This band was not present following reduction, however an intense band at 72 kDa and a weak band at 120 kDa (arrowed in Figure 9B 
DISCUSSION
The human MUC13 gene encodes an epithelial and hemopoietic transmembrane mucin.
MUC13 is the orthologue of a murine glycoprotein initially called 114/A10 or mouse cell surface antigen and hereto referred to as mMuc13. mMuc13 was initially identified by expression cloning using an antibody produced against a murine bone marrow-derived multipotential cell line (24) . mMuc13 had previously been found to be highly expressed in primary myeloid progenitor cells, the myelomonocytic leukaemia cell line WEHI-3 and various interleukin-3 dependent cell lines (22) . Spleen, liver, muscle and brain tissues were assessed as not expressing mMuc13, however, epithelial tissues were not examined.
The MUC13 gene is most highly expressed in epithelial tissues, particularly those of the gastrointestinal and respiratory tracts. In the large intestine, MUC13 is expressed on the apical cell surface of both goblet and columnar cells deep in the crypts confirming its role as a transmembrane mucin. Presence on the apical membrane of crypt epithelium mirrors the expression of two other cell surface mucins, MUC1 and MUC4, which also predominate in the crypts and are expressed by both major cell types (25) . In contrast, MUC3 (26) , and MUC12
It is now apparent that there is considerable multiplicity of expression of these cellsurface glycoproteins, especially in the gastrointestinal tract, and in particular, the large intestine.
In fact, MUC1 and MUC13 appear to be co-expressed, both intracellularly and on the same cell surfaces, in many places of the gastrointestinal tract. However, there is evidence of differential regulation of cell surface mucins throughout the gastrointestinal tract. For example, although MUC1 and MUC13 appear similarly expressed in the colon (27) and in the stomach (28), staining of serial sections with a MUC1-reactive antibody revealed differing patterns of expression of MUC13 and MUC1 in gastric tissue (data not shown). As a further example, in the surface epithelium MUC3 is expressed most highly in the small intestine and decreases distally with only low expression in the distal large intestine (26) . MUC12 expression increases progressively from small intestine to rectum 2 and similarly, MUC13 mRNA expression increases from small intestine to rectum.
In addition to multiplicity of expression, it is now apparent that there is considerable dynamism of cell-surface mucin expression in the gastrointestinal tract. For example, as cells in the large intestine migrate from deep in the crypts to the surface, they must undergo a major switch in their dominant cell-surface mucin proteins from MUC1, 4 and 13 to MUC3 and 12.
MUC13 is also very highly expressed in the trachea where it is also now apparent that there is considerable multiplicity of expression with MUC1 and 4 also being expressed. The expression of multiple cell-surface mucins with similar functional roles may explain why Muc1 null mice show no obvious signs of epithelial pathology (29) ; although these mice are also yet to be tested comprehensively with epithelial challenges. Interestingly, when Muc1 null mice were removed and that the mucin domain is cleaved from the transmembrane subunit, as occurs for both MUC1 and MUC4 (13, 14) . The C-terminal subunit containing the cytoplasmic tail is hereto referred to as the β-subunit using the terminology introduced for MUC4 (8) . The β-subunit appears to undergo homo-dimerization that is dependent on intra-chain disulfide bonds. and requires further investigation. Additional antibodies reactive with α-subunit epitopes need to be generated to confirm these conclusions. However, it is clear that the MUC13 β-subunit undergoes homo-oligomerization into dimers and that oligomerization is dependent on intrastrand disulphide bonds.
The role of cell surface mucins in epithelial tissues is not clearly understood. The complexity and level of expression is greatest in epithelial surfaces exposed to antigenically and chemically complex luminal environments. Based on knowledge of their structure and expression patterns it is likely that these molecules play an important role in barrier function. In addition to presenting large extended heavily glycosylated mucin domains on the cell-surface, highly conserved structural features suggest that an ability to shed the extracellular mucin domain and to report via cytoplasmic domain signaling are important facets of these cell-surface molecules. The signaling pathways triggered by cell surface mucins such as MUC13 remain to be elucidated although it appears that MUC1 can activate the ras pathway via Grb2 (32) and interact with β-catenin, an important modulator of cell adhesion and growth (33, 34) . Interactions between secreted mucins and bacteria have been well characterized (35) Muc13 was also identified as being associated with megakaryocyte maturation and platelet formation (37) . Upregulation of mMuc13 in a murine megakaryoblastic cell line, L8057, when differentiating into a megakaryocytic lineage, suggested mMuc13 could be involved with cell differentiation and maturation. Overexpression of mMuc13 was found to inhibit cell adhesion to fibronectin suggesting it could act as a negative regulator of cell adhesion in the megakaryocytic lineage. We also observed strong expression of mMuc13 in intestinal-associated lymphoid tissue, and weaker expression in lymphoid cells in both the red pulp and follicles of the spleen. MUC13
is clearly expressed by mature lymphoid cells and this requires further characterization.
In summary, we have determined the complete cDNA sequence of a novel human mucin gene, MUC13, and shown that this gene encodes a cell surface and secreted mucin that is most highly expressed in epithelial tissues but is also found in some hemopoietic cells. Our future research will concentrate on the role of the MUC13 mucin protein in non-malignant and malignant epithelial diseases, particularly those of the gastrointestinal tract. 
